Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening

By Cottet Martin   Faklaris Orestis   Zwier Jurriaan M.   Trinquet Eric   Pin Jean-Philippe   Durroux Thierry  

Pharmaceuticals, Vol. 4, Iss. 1, 2011-01 ,pp. : 202-214

MDPI

Access to resources Recommend Favorite

Number of Axillary Lymph Node Metastases Determined by Preoperative Ultrasound is Related to Prognosis in Patients with Breast Cancer

By Kijima Yuko   Yoshinaka Heiji   Hirata Munetsugu   Mizoguchi Tadao   Ishigami Sumiya   Nakajo Akihiro   Arima Hideo   Ueno Shinichi   Natsugoe Shoji  

Cancers, Vol. 2, Iss. 1, 2010-02 ,pp. : 20-31

MDPI

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

By Xue Caifu   Zhang Xunjie   Cai Weimin  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion

By Sakurada Tomoya   Yoshikawa Masaharu   Sunaga Masahiko   Kobayashi Eriko   Satoh Nobunori   Yokosuka Osamu   Ueda Shiro  

Pharmaceutics, Vol. 2, Iss. 3, 2010-09 ,pp. : 300-312

MDPI

Access to resources Recommend Favorite

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

By Novo Salvatore   Fazio Giovanni   Raccuglia Elena  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-11 ,pp. : 118-124

MDPI

Access to resources Recommend Favorite